Clovique

Active Ingredient(s): Trientine Hydrochloride
FDA Approved: * October 21, 2019
Pharm Company: * KADMON PHARMS LLC
Category: Genetic Disorders

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Clovique Overview

Triethylenetetramine (TETA and trien), also called trientine (INN), is an organic compound with the formula [CH2NHCH2CH2NH2]2. This oily liquid is colorless but, like many amines, assumes a yellowish color due to impurities resulting from air-oxidation. It is soluble in polar solvents. The branched isomer tris(2-aminoethyl)amine and piperazine derivatives may also be present in commercial samples of TETA.[1] Contents 1 Uses 2 Cost 3 Production 4 Coordination chemistry 5 Ref...

Read more Clovique Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Triethylenetetramine

Recent Clovique Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Trientine Hydrochloride
  • Capsule: 250mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Trientine Hydrochloride or a similar ingredient: (3 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 9 July 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA